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Abstract
Background: Osteopathic manipulative treatment (OMT) is a distinctive modality commonly used by
osteopathic physicians to complement their conventional treatment of musculoskeletal disorders.
Previous reviews and meta-analyses of spinal manipulation for low back pain have not specifically addressed
OMT and generally have focused on spinal manipulation as an alternative to conventional treatment. The
purpose of this study was to assess the efficacy of OMT as a complementary treatment for low back pain.
Methods: Computerized bibliographic searches of MEDLINE, EMBASE, MANTIS, OSTMED, and the
Cochrane Central Register of Controlled Trials were supplemented with additional database and manual
searches of the literature.
Six trials, involving eight OMT vs control treatment comparisons, were included because they were
randomized controlled trials of OMT that involved blinded assessment of low back pain in ambulatory
settings. Data on trial methodology, OMT and control treatments, and low back pain outcomes were
abstracted by two independent reviewers. Effect sizes were computed using Cohen's d statistic and meta-
analysis results were weighted by the inverse variance of individual comparisons. In addition to the overall
meta-analysis, stratified meta-analyses were performed according to control treatment, country where the
trial was conducted, and duration of follow-up. Sensitivity analyses were performed for both the overall
and stratified meta-analyses.
Results: Overall, OMT significantly reduced low back pain (effect size, -0.30; 95% confidence interval, -
0.47 – -0.13; P = .001). Stratified analyses demonstrated significant pain reductions in trials of OMT vs
active treatment or placebo control and OMT vs no treatment control. There were significant pain
reductions with OMT regardless of whether trials were performed in the United Kingdom or the United
States. Significant pain reductions were also observed during short-, intermediate-, and long-term follow-
up.
Conclusion:  OMT significantly reduces low back pain. The level of pain reduction is greater than
expected from placebo effects alone and persists for at least three months. Additional research is
warranted to elucidate mechanistically how OMT exerts its effects, to determine if OMT benefits are long
lasting, and to assess the cost-effectiveness of OMT as a complementary treatment for low back pain.
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Background
Historically, low back pain has been the most common
reason for visits to osteopathic physicians [1]. More recent
data from the Osteopathic Survey of Health Care in Amer-
ica has confirmed that a majority of patients visiting oste-
opathic physicians continue to seek treatment for
musculoskeletal conditions [2,3]. A distinctive element of
low back care provided by osteopathic physicians is oste-
opathic manipulative treatment (OMT). A comprehensive
evaluation of spinal manipulation for low back pain
undertaken by the Agency for Health Care Policy and
Research in the United States concluded that spinal
manipulation can be helpful for patients with acute low
back problems without radiculopathy when used within
the first month of symptoms [4]. Nevertheless, because
most studies of spinal manipulation involve chiropractic
or physical therapy [5], it is unclear if such studies ade-
quately reflect the efficacy of OMT for low back pain.
Although the professional associations that represent
osteopaths, chiropractors, and physiotherapists in the
United Kingdom developed a spinal manipulation pack-
age consisting of three common manual elements for use
in the UK Back pain Exercise and Manipulation (UK
BEAM) trial [6], there are no between-profession compar-
isons of clinical outcomes [7,8]. It is well known that
OMT comprises a diversity of techniques [9] that are not
adequately represented by the UK BEAM trial package.
Professional differences in spinal manipulation are more
pronounced in research studies, where chiropractors have
focused almost exclusively on high-velocity-low-ampli-
tude techniques [10]. For example, a major trial of chiro-
practic manipulation as adjunctive treatment for
childhood asthma used a high-velocity-low-amplitude
thrust as the active treatment [11]. The simulated treat-
ment provided in the sham manipulation arm of this chi-
ropractic trial, which ostensibly was thought to have no
therapeutic effect, had a marked similarity to OMT
[10,12]. Further, because differences in professional back-
ground and training lend themselves to diverse manipula-
tion approaches, clinicians have been warned about
generalizing the findings of systematic reviews to practice
[13].
In addition to professional differences in the manual tech-
niques themselves, osteopathic physicians in the United
States, unlike allopathic physicians, chiropractors, or
physical therapists, can treat low back pain simultane-
ously using both conventional primary care approaches
and complementary spinal manipulation. This represents
a unique philosophical approach in the treatment of low
back pain. Consequently, there is a need for empirical
data that specifically address the efficacy of OMT for such
conditions as low back pain [14]. The present study was
undertaken to address this need by conducting a system-
atic review of the literature on OMT and performing a
meta-analysis of all randomized controlled trials for low
back pain performed in ambulatory settings.
Methods
Search
A search of the English language literature was performed
through August 2003 to identify reports of randomized
controlled trials of OMT. We searched MEDLINE, OLDM-
EDLINE, EMBASE, MANTIS, OSTMED, Alt Health Watch,
SciSearch, ClinicalTrials.gov, CRISP, and the Cochrane
Central Register of Controlled Trials. A detailed descrip-
tion of the search strategy is provided in the Appendix [see
Additional file 1]. Additionally, reports were sought from
relevant reviews or meta-analyses of spinal manipulation
[9,15-32] and manual searches of reference citations in
the reviewed literature sources.
Selection
The search bibliographies and relevant reports were
reviewed by the authors to identify randomized control-
led trials involving OMT in human subjects. To assess the
efficacy of OMT in primary care, eligibility was limited to
randomized controlled trials of OMT performed by osteo-
paths, osteopathic physicians, or osteopathic trainees that
included blinded assessment of low back pain in ambula-
tory settings. Trials that involved manipulation under
anesthesia, industrial settings, or hospitalized patients
were not included. Because there is potential confusion
regarding the type of manipulation performed in some tri-
als [33], the reported methods in each trial were carefully
reviewed to assess eligibility for the meta-analysis. Over-
all, seven studies known or purported to involve OMT for
low back pain were reviewed and excluded for not meet-
ing all eligibility criteria [34-40]. A subsequent source [41]
indicated that an osteopathic manipulation technique
was used in the Irvine study [42]. Although several of the
six included OMT trials were identified in multiple bibli-
ographic databases, five [42-46] were indexed in
MEDLINE. The Cleary [47] trial was identified exclusively
through the Cochrane Central Register of Controlled
Trials.
Data extraction
Each eligible trial was independently reviewed by two of
us to abstract data on methodological characteristics,
OMT and control treatments, and low back pain out-
comes. Conflicting data were resolved by consensus.
Trial characteristics
As shown in Table 1, the six OMT trials were conducted
between 1973 and 2001 in the United Kingdom or the
United States [42-47]. Two of the six trials each included
two control treatments [43,46], thus providing eight OMT
vs control treatment comparisons. The trials generallyBMC Musculoskeletal Disorders 2005, 6:43 http://www.biomedcentral.com/1471-2474/6/43
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Table 1: Summary of trials.
Hoehler 1981 [42] Gibson 1985 [43] Cleary 1994 [47]
Years conducted 1973–1979 ... 1991–1992
Country United States United Kingdom United Kingdom
Setting University clinic Hospital outpatient clinic Ambulatory clinic
No. of subjects randomized 95 109 30*
Comparison OMT vs soft tissue massage and sham 
manipulation
OMT vs short-wave diathermy
OMT vs detuned short-wave 
diathermy
OMT vs sham manipulation
Subject
characteristics
Age, y
Mean ± SD OMT, 30.1 ± 8.4
Controls, 32.1 ± 9.8
OMT, 34 ± 14
Short-wave diarthermy controls, 35 ± 
16
Detuned short-wave diathermy 
controls, 40 ± 16
Overall age range, 50–60
Sex
% male OMT, 59
Controls, 59
OMT, 49
Detuned short-wave diathermy 
controls, 68
Short-wave diarthermy controls, 53
OMT, 0
Controls, 0
Type of low back pain Referred patients with acute or 
chronic low back pain
Referred patients with low back pain 
of greater than 2 months' and less 
than 12 months' duration
Recruited subjects with chronic low 
back pain in conjunction with 
menopausal symptoms
OMT protocol
Technique High-velocity, low-amplitude thrust 
only
Variety of techniques Low-force techniques
No. of treatments
Mean ± SD OMT, 4.8 ± 2.7
Controls, 3.9 ± 2.5
4, per protocol 10, per protocol
Outcomes assessment Blinded Blinded Assessment independent of 
treatment, blinding not specified
No. of pain contrasts 3 6 (3 for each of the two OMT vs 
control treatment comparisons)
1
Type of pain outcome Dichotomous pain outcomes Dichotomous pain outcomes Dichotomous pain outcome
Timing of pain contrasts
Short-term First treatment and mean, 20–30 days 
following randomization
2 and 4 weeks ...
Intermediate-term Mean, 41–51 days following 
randomization
... ...
Long-term ... 12 weeks 15 weeks
Andersson 1999 [44] Burton 2000 [45] Licciardone 2003 [46]
Years conducted 1992–1994 ... 2000–2001
Country United States United Kingdom United States
Setting Health maintenance organization Hospital orthopedic department University clinic
No. of subjects randomized 178 40 91
Comparison Usual care and OMT vs usual care 
only
OMT vs chemonucleolysis Usual care and OMT vs usual care and 
sham manipulation
Usual care and OMT vs usual care 
only
Subject characteristics
Age, y
Mean ± SD OMT, 28.5 ± 10.6
Controls, 37.0 ± 11.0
Overall, 41.9 ± 10.6 Usual care and OMT, 49 ± 12
Usual care and sham manipulation 
controls, 52 ± 12
Usual care only controls, 49 ± 12
Sex
% male OMT, 41
Controls, 44
Overall, 48 Usual care and OMT, 31
Usual care and sham manipulation 
controls, 43
Usual care only controls, 35
Type of low back pain Patients with low back pain of 3 or 
more weeks' and less than 6 months' 
duration
Recruited patients with low back pain 
and sciatica; mean duration, 30 and 32 
weeks in OMT and chemonucleolysis 
groups, respectively
Recruited subjects with low back pain 
of at least 3 months' duration
OMT protocolBMC Musculoskeletal Disorders 2005, 6:43 http://www.biomedcentral.com/1471-2474/6/43
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were comparable in their methodology, with the possible
exception of the Cleary [47] trial. Twenty contrasts were
reported in the six trials (a contrast refers to a within-trial
comparison between OMT and a control treatment with
respect to a low back pain outcome at a given point in
time). Following randomization, nine contrasts were
reported within one month (short-term outcomes),
another seven contrasts were reported within three
months (intermediate-term outcomes), and the remain-
ing four contrasts were reported within 12 months (long-
term outcomes).
Technique Variety of techniques, individualized 
to patient
Variety of techniques, individualized 
to patient
Variety of techniques, individualized 
to subject
No. of treatments
Mean ± SD 8, per protocol Mean for OMT, 11; range 6–18 7, per protocol
Outcomes assessment Blinded Blinded Blinded
No. of pain contrasts 1 3 6 (3 for each of the two OMT vs 
control treatment comparisons)
Type of pain outcome Pain scale Pain scales Pain scales
Timing of pain contrasts
Short-term ... 2 weeks 1 month
Intermediate-term 12 weeks 6 weeks 3 months
Long-term ... 12 months 6 months
OMT denotes osteopathic manipulative treatment.
*A total of 30 subjects with menopausal symptoms were randomized; however, only 12 subjects had low back pain.
Table 2: Summary of analyses.*
Meta-Analyses Sensitivity Analyses
Overall Median Contrasts Best-case and worst-case scenarios
4 possible combinations of contrasts including one control treatment per trial
Cleary [47] trial excluded
All 20 contrasts
Stratified Median Contrasts
A. Control Treatment
1. Active treatment or placebo control Best-case and worst-case scenarios
2 possible combinations of contrasts including one control treatment per trial
Cleary [47] trial excluded
All 16 contrasts
2. No treatment
B. Country Where Trial was Performed
3. United Kingdom Best-case and worst-case scenarios
2 possible combinations of contrasts including one control treatment per trial
Cleary [47] trial excluded
All 10 contrasts
4. United States Best-case and worst-case scenarios
2 possible combinations of contrasts including one control treatment per trial
All 10 contrasts
C. Duration of Follow-Up
5. Short-term Best-case and worst-case scenarios
All 9 contrasts
6. Intermediate-term 4 possible combinations of contrasts including one control treatment per trial
7. Long-term 2 possible combinations of contrasts including one control treatment per trial 
Cleary [47] trial excluded
*There were insufficient contrasts to perform sensitivity analyses for the no treatment stratified analysis. For the short-term stratified analysis, the 
median contrast was defined to be that corresponding to the eighth combination when effect sizes for the 16 possible contrast combinations were 
rank ordered from least to greatest. For the intermediate-and long-term stratified analyses, the median contrasts defaulted to the all-contrasts 
analyses because there were no repeated measures within these time intervals in any trial. All possible contrast combinations were included in the 
sensitivity analyses for intermediate-and long-term follow-up because of the limited numbers of combinations for these analyses.
Table 1: Summary of trials. (Continued)BMC Musculoskeletal Disorders 2005, 6:43 http://www.biomedcentral.com/1471-2474/6/43
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The methodological quality of four of the OMT trials [42-
45] was independently confirmed in a recent systematic
review that included a best evidence synthesis incorporat-
ing eight explicit quality criteria, including similarity of
baseline characteristics of subjects or reporting of adjusted
outcomes; concealment of treatment allocation; blinding
of subjects; blinding of providers or other control for
attention bias; blinded or unbiased outcomes assessment;
subject dropouts reported and accounted for in the analy-
sis; missing data reported and accounted for in the analy-
sis; and intention-to-treat analysis or absence of
differential co-interventions between groups in studies
with full compliance [13]. The Cleary [47] trial was not
eligible for this review because it did not include a suffi-
ciently large number of subjects. Although the Licciardone
[46] trial was not eligible for the review because it was
published after the closing date of December 2002, it has
been characterized as an innovative and important trial
with many rigorous design features [48], and more
recently has been identified as an evidence-based supple-
ment relative to the previous review from the Cochrane
Library [49].
Quantitative data synthesis
We used the effect size, computed as Cohen's d statistic, to
report all trial results [50]. A negative effect size repre-
sented a greater decrease in pain among OMT subjects rel-
ative to control treatment subjects. Dichotomous pain
measures were transformed to effect sizes by first comput-
ing the relevant P-value and then determining the effect
size and 95% confidence interval (CI) that would obtain
under the assumption of a two-tailed t-test for measuring
the standardized mean difference between OMT and con-
trol treatments in the relevant number of subjects [50].
The meta-analysis results were weighted by the inverse
variance for each OMT vs control treatment comparison.
The Q statistic was used to test the homogeneity of trials
included in each analysis [51].
The overall meta-analysis included the eight OMT vs con-
trol treatment comparisons. Four of the six trials, involv-
ing six of the eight OMT vs control treatment
comparisons, each reported three contrasts [42,43,45,46]
(Table 1). The median contrast, as identified by the inter-
mediate effect size among the three reported pain out-
comes for a given OMT vs control treatment comparison,
was used to represent the pain outcome for each of these
six comparisons. These median contrasts were then
combined with the lone contrasts reported in each of the
two remaining OMT vs control treatment comparisons
[44,47]. Based on the similarity among trials (Table 1), a
fixed-effects model initially was used to perform meta-
analysis and the results were then compared with those of
a random-effects model.
Flowchart of trials Figure 1
Flowchart of trials.
Potentially relevant
reports identified during
original searches (n=389)
Excluded reports (n=268)
· Not related to osteopathic
manipulative treatment
· Duplicate reports
· False drops
Screened reports based
on available title, subject,
heading, or abstract (n=121)
Excluded reports (n=75)
· Not related to osteopathic
manipulative treatment
· Did not meet randomized
controlled trial criteria
Retrieved reports for
detailed evaluation (n=46)
Excluded reports (n=29)
· Not related to osteopathic
manipulative treatment
· Did not meet meta-analysis
inclusion criteria
Evaluated reports for low
back pain outcomes (n=17)
Excluded reports (n=11)
· Antibody response to
hepatitis B vaccine
· Bronchial asthma
· Bronchiolitis
· Fibromyalgia
· Menstrual cramps
· Muscle contraction headaches
· Shoulder pain
· Otitis media
· Pancreatitis
· Pneumonia
· Post-operative atelectasis
Included randomized controlled
trials (n=6): 8 osteopathic
manipulative treatment vs
control treatment comparisonsBMC Musculoskeletal Disorders 2005, 6:43 http://www.biomedcentral.com/1471-2474/6/43
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A series of sensitivity analyses were then performed. First,
to address the possibility of bias by using the median con-
trasts method, analyses were repeated using the best-case
and worst-case scenarios for the six relevant OMT vs con-
trol treatment comparisons [42,43,45,46]. Second, to
address the possibility of bias by including comparisons
involving the same OMT group vs two different control
treatment groups in two trials [43,46], analyses were
repeated using only one OMT vs control treatment com-
parison for each of these trials. Each of the four possible
combinations of contrasts was analyzed. Third, the analy-
sis was repeated after excluding the Cleary [47] trial.
Finally, an analysis was performed using all 20 low back
pain contrasts. Similar analyses were performed after strat-
ifying trials according to control treatment, country where
the trial was performed, and duration of follow-up.
As summarized in Table 2, there were 43 analyses per-
formed, including the overall meta-analysis, seven strati-
fied meta-analyses, and 35 sensitivity analyses. Meta-
analysis was performed only when there were at least
three contrasts available for data synthesis. Database man-
agement and analyses were performed using the Compre-
hensive Meta-Analysis software package (Version 1.0.23,
Biostat, Inc, Englewood, NJ 07631, USA).
Results
Overall analyses
The search for reports is summarized in Figure 1. A total
of 525 subjects with low back pain were randomized in
the eligible trials. The overall results are presented in Fig-
ure 2. There was a highly significant reduction in pain
associated with OMT (effect size, -0.30; 95% CI, -0.47 – -
0.13; P = .001). The Q statistic was non-significant, thus
supporting the assumption of homogeneity among trials.
The primary sensitivity analyses are presented in Table 3.
Using a random-effects model, the results were virtually
identical to those observed with a fixed-effects model.
There were 729 (36 × 12) possible combinations of con-
trasts for analysis based on three contrasts for each of six
OMT vs control treatment comparisons [42,43,45,46] and
one contrast for each of the two remaining OMT vs con-
trol treatment comparisons [44,47]. The efficacy of OMT
for low back pain was supported in both the best-case
(effect size, -0.37; 95% CI, -0.55 – -0.20; P < .001) and
worst-case (effect size, -0.18; 95% CI, -0.35 – 0.00; P =
.046) scenarios. Similarly, when each trial was limited to
one OMT vs control treatment comparison, OMT was
found to be efficacious in each of the four analyses. OMT
also demonstrated significantly greater low back pain
reduction than control treatment in analyses with the
Cleary [47] trial excluded and with all 20 contrasts
included.
Stratified analyses
The results of stratified meta-analyses are presented in
Table 4. There was a significant reduction in low back pain
associated with OMT in trials vs active treatment or pla-
cebo control (effect size, -0.26; 95% CI, -0.48 – -0.05; P =
.02), independent of fixed-effects or random-effects
model specification. There were 243 (35 × 11) possible
contrast combinations based on three contrasts for each
Effect size for low back pain Figure 2
Effect size for low back pain. CI denotes confidence interval; OMT, osteopathic manipulative treatment. Overall effect size, -
0.30; 95% CI, -0.47 – -0.13; P = .001.
Control No. of subjects
Source, year treatment
Hoehler 1981 [42] Active and placebo 56 39 17
Gibson 1985 [43] Active treatment 38 27 12
Gibson 1985 [43] Placebo control 39 33 14
Cleary 1994 [47] Placebo control 8 4 2
Andersson 1999 [44] No treatment 83 72 29
Burton 2000 [45] Active treatment 20 20 8
Licciardone 2003 [46] Placebo control 32 19 9
Licciardone 2003 [46] No treatment 42 17 9
Overall 318 231 100
Effect size (95% CI) Weight Control OMT
-2.00 -1.00 0.00 1.00 2.00
Favors OMT Favors ControlBMC Musculoskeletal Disorders 2005, 6:43 http://www.biomedcentral.com/1471-2474/6/43
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of five OMT vs control treatment comparisons
[42,43,45,46] and one contrast for another remaining
OMT vs control treatment comparison [47]. Both the best-
case and worst-case scenarios demonstrated a greater
reduction in pain with OMT than active treatment or pla-
cebo control, although the worst-case results did not
achieve statistical significance. OMT was found to signifi-
cantly reduce pain in the remaining analyses that limited
OMT vs active treatment or placebo control comparisons
to one per trial, excluded the Cleary [47] trial, and
included all 16 contrasts. The OMT vs no treatment con-
trol comparisons were observed in trials in which all sub-
jects received usual low back care in addition to their
allocated treatment (ie, OMT and usual care vs only usual
care) [44,47]. For these trials, the all-contrasts model (ie,
the only model with sufficient contrasts for data synthe-
sis) demonstrated a highly significant reduction in pain
with OMT.
Trials in both the United Kingdom (effect size, -0.29; 95%
CI, -0.58 – 0.00; P = .050) and the United States (effect
size, -0.31; 95% CI, -0.52 – -0.10; P = .004) demonstrated
significant reductions in low back pain associated with
OMT. In the sensitivity analyses, effect sizes were generally
of comparable magnitude in both countries, although
results in American trials consistently achieved statistical
significance as a consequence of the larger sample sizes in
these trials (Table 4).
There were significant reductions in low back pain associ-
ated with OMT during the short-term (effect size, -0.28;
95% CI, -0.51 – -0.06; P = .01), intermediate-term (effect
size, -0.33; 95% CI, -0.51 – -0.15; P < .001), and long-term
(effect size, -0.40; 95% CI, -0.74 – -0.05; P = .03) follow-
up periods. Sensitivity analyses for temporal outcomes
demonstrated that intermediate-term results consistently
achieved statistical significance, generally because of the
greater number of subjects in these analyses (Table 4). The
results of the meta-analyses and sensitivity analyses are
further summarized in Figure 3.
Discussion
Efficacy of osteopathic manipulative treatment
The overall results clearly demonstrate a statistically sig-
nificant reduction in low back pain with OMT (Figure 2).
Further, the meta-analysis results are quite robust as indi-
cated by the comprehensive sensitivity analyses (Figure
3). Stratified meta-analyses to control for moderator vari-
ables demonstrated that OMT significantly reduced low
back pain vs active treatment or placebo control and vs no
treatment control. If it is assumed, as shown in a review
[52], that the effect size is -0.27 for placebo control vs no
treatment in trials involving continuous measures for
pain, then the results of our study are highly congruent
(ie, effect size for OMT vs no treatment [-0.53] = effect size
for OMT vs active treatment or placebo control [-0.26] +
effect size for placebo control vs no treatment [-0.27]).
It has been suggested that the therapeutic benefits of spi-
nal manipulation are largely due to placebo effects [53]. A
preponderance of results from our sensitivity analyses
supports the efficacy of OMT vs active treatment or pla-
cebo control and therefore indicates that low back pain
reduction with OMT is attributable to the manipulation
techniques, not merely placebo effects. Also, as indicated
above, OMT vs no treatment control demonstrated pain
reductions twice as great as previously observed in clinical
trials of placebo vs no treatment control [52]. Thus, OMT
Table 3: Overall results.
No. of Subjects
Model No. of
Contrasts
OMT Control Effect
Size
95% CI P
Median contrasts
Fixed-effects model* 8 318 231 -0.30 -0.47 – -0.13 .001
Random-effects model 8 318 231 -0.31 -0.49 – -0.13 .001
Best-case scenario 8 293 220 -0.37 -0.55 – -0.20 <.001
Worst-case scenario 8 298 221 -0.18 -0.35 – 0.00 .046
Median contrasts, one OMT vs control treatment comparison per trial
Gibson [43] active treatment control and Licciardone [46] placebo control 6 237 181 -0.30 -0.49 – -0.10 .003
Gibson [43] active treatment control and Licciardone [46] no treatment 
control
6 247 179 -0.39 -0.59 – -0.20 <.001
Gibson [43] placebo control and Licciardone [46] placebo control 6 238 187 -0.26 -0.45 – -0.06 .01
Gibson [43] placebo control and Licciardone [46] no treatment control 6 248 185 -0.35 -0.54 – -0.15 <.001
Median contrasts, Cleary [47] trial excluded 7 310 227 -0.29 -0.47 – -0.12 .001
All contrasts 20 727 520 -0.29 -0.40 – -0.17 <.001
CI denotes confidence interval; OMT, osteopathic manipulative treatment.
*Test for homogeneity, P = .37.BMC Musculoskeletal Disorders 2005, 6:43 http://www.biomedcentral.com/1471-2474/6/43
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Table 4: Stratified results.
No. of Subjects
Model No. of
Contrasts
OMT Control Effect
Size
95% CI P
OMT vs. Active Treatment or Placebo Control
Median contrasts
Fixed-effects model* 6 193 142 -0.26 -0.48 – -0.05 .02
Random-effects model 6 193 142 -0.26 -0.48 – -0.05 .02
Best-case scenario 6 174 132 -0.34 -0.57 – -0.11 .004
Worst-case scenario 6 183 134 -0.07 -0.29 – 0.16 .54
Median contrasts, one OMT vs control treatment comparison per trial
Gibson [43] active treatment 5 154 109 -0.33 -0.58 – -0.08 .01
Gibson [43] placebo control 5 155 115 -0.26 -0.51 – -0.02 .03
Median contrasts, Cleary [47] trial excluded 5 185 138 -0.24 -0.47 – -0.02 .03
All contrasts 16 534 400 -0.21 -0.34 – -0.08 .002
OMT vs. No Treatment Control
All contrasts 4 193 120 -0.53 -0.76 – -0.30 <.001
Trials Performed in the United Kingdom
Median contrasts
Fixed-effects model* 4 105 84 -0.29 -0.58 – 0.00 .050
Random-effects model 4 105 84 -0.30 -0.63 – 0.02 .06
Best-case scenario 4 105 88 -0.36 -0.64 – -0.07 .01
Worst-case scenario 4 100 83 -0.11 -0.40 – 0.19 .48
Median contrasts, one OMT vs control treatment comparison per trial
Gibson [43] active treatment 3 66 51 -0.46 -0.83 – -0.09 .02
Gibson [43] placebo control 3 67 57 -0.30 -0.66 – 0.05 .10
Median contrasts, Cleary [47] trial excluded 3 97 80 -0.26 -0.56 – 0.04 .09
All contrasts 10 294 247 -0.23 -0.40 – -0.06 .01
Trials Performed in the United States
Median contrasts
Fixed-effects model* 4 213 147 -0.31 -0.52 – -0.10 .004
Random-effects model 4 213 147 -0.32 -0.57 – -0.06 .01
Best-case scenario 4 188 132 -0.38 -0.61 – -0.16 .001
Worst-case scenario 4 198 138 -0.22 -0.44 – 0.00 .050
Median contrasts, one OMT vs control treatment comparison per trial
Licciardone [46] placebo control 3 171 130 -0.24 -0.47 – -0.01 .04
Licciardone [46] no treatment control 3 181 128 -0.36 -0.59 – -0.14 .002
All contrasts 10 433 273 -0.33 -0.48 – -0.18 <.001
Short-Term Follow-Up
Median contrasts
Fixed-effects model* 5 181 130 -0.28 -0.51 – -0.06 .01
Random-effects model 5 181 130 -0.31 -0.61 – -0.01 .046
Best-case scenario 5 196 142 -0.41 -0.62 – -0.19 <.001
Worst-case scenario 5 181 136 -0.10 -0.32 – 0.12 .38
All contrasts 9 357 258 -0.23 -0.39 – -0.07 .01
Intermediate-Term Follow-Up
Median (all) contrasts
Fixed-effects model* 7 283 209 -0.33 -0.51 – -0.15 <.001
Random-effects model 7 283 209 -0.36 -0.63 – -0.10 .01
Median contrasts, one OMT vs control treatment comparison per trial
Gibson [43] active treatment and Licciardone [46] placebo control 5 209 161 -0.31 -0.52 – -0.10 .004
Gibson [43] active treatment and Licciardone [46] no treatment control 5 209 158 -0.45 -0.65 – -0.24 <.001
Gibson [43] placebo control and Licciardone [46] placebo control 5 209 166 -0.25 -0.46 – -0.05 .02
Gibson [43] placebo control and Licciardone [46] no treatment control 5 209 163 -0.39 -0.59 – -0.18 <.001BMC Musculoskeletal Disorders 2005, 6:43 http://www.biomedcentral.com/1471-2474/6/43
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may eliminate or reduce the need for drugs that can have
serious adverse effects [44].
Because osteopathic physicians provide OMT to comple-
ment conventional treatment for low back pain, they tend
to avoid substantial additional costs that would otherwise
be incurred by referring patients to chiropractors or other
practitioners [54]. With respect to back pain, osteopathic
physicians make fewer referrals to other physicians and
admit a lower percentage of patients to hospitals than
allopathic physicians [1], while also treating back pain
episodes with substantially fewer visits than chiropractors
[55]. Although osteopathic family physicians are less
likely to order radiographs or prescribe nonsteroidal anti-
inflammatory drugs, aspirin, muscle relaxants, sedatives,
and narcotic analgesics for low back pain than their allo-
pathic counterparts, osteopathic physicians have a sub-
stantially higher proportion of patients returning for
follow-up back care than allopathic physicians [56]. In the
United Kingdom, where general practitioners may refer
patients with spinal pain to osteopaths for manipulation,
it has been shown that OMT improved physical and psy-
chological outcomes at little extra cost [57].
In our study, the effect sizes for OMT in the United King-
dom, where osteopaths are not licensed physicians, were
generally comparable to those in the United States, where
OMT is provided by licensed physicians. This consistency
suggests that the results truly reflect the effects of OMT
itself, and not other elements of low back care. It is not
surprising that osteopaths in the United Kingdom
achieved pain reduction with OMT similar to that of their
physician counterparts in the United States. The training
of osteopaths in the United Kingdom is highly focused on
OMT, whereas osteopathic physicians undertake a
medical curriculum that necessarily relegates OMT to one
of many therapeutic approaches, albeit a fundamental
one for osteopathic practitioners. Regardless of the career
training path of the provider, it appears that OMT
achieves clinically important reductions in low back pain.
Potential limitations
There are several potential limitations of this study that
should be addressed. First, as with any meta-analysis, the
individual trials varied somewhat with respect to method-
ology, including trial setting, subject characteristics, OMT
and control treatment interventions, and pain measures
(Table 1). Such heterogeneity has been commonly
observed in previous meta-analyses of spinal manipula-
tion, including a recent meta-analysis performed in col-
laboration with the Cochrane Back Review Group [31].
The latter study addressed potential heterogeneity by pre-
senting stratified results according to chronicity of low
back pain, type of control group, and duration of follow-
up. This approach is analogous to the methods used in
our study. Further, it should be noted that the assumption
of homogeneity among trials was not rejected statistically
in any of our eight overall or stratified median contrasts
meta-analyses.
Second, because five trials each included repeated pain
measures and two trials each included two control treat-
ments, there was no unique set of independent outcomes
for meta-analysis. Such interdependencies were noted to
be a problem in an early meta-analysis of spinal manipu-
lation [15]. We used the median contrasts method to
address this problem because the median outcome repre-
sents an observed outcome that is easy to compute and is
less vulnerable to extreme observations than other meas-
ures of central tendency. Further, sensitivity analysis was
used to assess the range of possible combinations of out-
comes. Thus, for the overall meta-analysis, there were 729
potential contrast combinations. Of these, both the best-
case and worst-case scenarios demonstrated statistically
significant results favoring OMT, thereby providing une-
quivocal evidence for the efficacy of OMT. Robust find-
Long-Term Follow-Up
Median (all) contrasts
Fixed-effects model* 4 87 53 -0.40 -0.74 – -0.05 .03
Random-effects model 4 87 53 -0.41 -0.82 – -0.01 .046
Median contrasts, one OMT vs control treatment comparison per trial
Licciardone [46] placebo control 3 55 38 -0.23 -0.65 – 0.19 .28
Licciardone [46] no treatment control 3 55 34 -0.64 -1.08 – -0.20 .01
Median contrasts, Cleary [47] trial excluded 3 79 49 -0.36 -0.72 – 0.01 .054
CI denotes confidence interval; OMT, osteopathic manipulative treatment.
*Tests of homogeneity, P = .45 and P = .06 for active treatment or placebo control, and no treatment control groups, respectively; P = .32 and P = 
.26 for trials in the United Kingdom and the United States, respectively; and P = .14, P = .06, and P = .28 for short-term, intermediate-term, and 
long-term follow-up, respectively.
Table 4: Stratified results. (Continued)BMC Musculoskeletal Disorders 2005, 6:43 http://www.biomedcentral.com/1471-2474/6/43
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ings were also observed for trials performed in the United
States and for intermediate-term outcomes.
Third, because there were a relatively small number of eli-
gible trials, there were not sufficient contrasts for certain
analyses and some results were imprecise. The latter phe-
nomenon likely obviated the statistical significance of
some results. Nevertheless, it is important to note that the
direction of results favored OMT in each of the 43 meta-
analyses and sensitivity analyses presented herein (Figure
3).
Fourth, there exists the possibility that the results of
unpublished trials of OMT for low back pain may have
altered significantly the conclusions of this study. To
address this issue, we performed file drawer analysis by
computing the fail-safe N [58]. This represents the
number of unpublished trials of OMT for low back pain
that would have met our inclusion criteria, and that also
would have demonstrated an effect size averaging ≥ -0.10,
which is assumed to reflect clinically insignificant levels of
pain reduction. A total of 16 unpublished trials (assuming
one control group per trial) with, in the aggregate, clini-
cally insignificant pain reduction outcomes would have
been needed to obviate the significance of our results.
Only recently has government funding for research in the
area of complementary and alternative medicine become
more widely available, in response to the public's interest
in such treatments. Historically, it is highly unlikely that
16 trials of OMT for low back pain would have been spon-
sored, conducted, and subsequently not published.
Finally, this study focused only on the efficacy of OMT
with respect to pain outcomes. Generic health status,
back-specific function, work disability, and back-specific
patient satisfaction are other recommended outcome
domains [59] that were not assessed because the included
OMT trials did not consistently report these data.
Conclusion
The present study indicates that OMT is a distinctive
modality that significantly reduces low back pain. The
level of pain reduction is greater than expected from pla-
cebo effects alone and persists for at least three months.
Additional research is warranted to elucidate mechanisti-
cally how OMT exerts its effects, to determine if OMT ben-
Summary of meta-analysis results Figure 3
Summary of meta-analysis results. A denotes all-contrasts model; B, best-case scenario model; C, Cleary [47] trial excluded 
model; M, median contrasts model; NT, no treatment control; OMT, osteopathic manipulative treatment; W, worst-case sce-
nario model. 1, 2, 3, and 4 indicate alternative models restricted to one OMT vs control treatment comparison per trial. A dia-
mond indicates the inclusion of the relevant contrast or observation of the stated result. Sensitivity analyses are shaded in gray. 
Results are presented for each of the 43 analyses, including the overall meta-analysis, seven stratified meta-analyses, and 35 
sensitivity analyses.
NT
Comparison Duration of
Source, year treatment follow-up M B W 1 2 3 4 C A M B W 1 2 C A M M B W 1 2 C A M B W 1 2 A M B W A M 1 2 3 4 M 1 2 C
Hoehler 1981[42] Active and placebo Immediate        
Hoehler 1981 [42] Active and placebo 20-30 Days        
Hoehler 1981 [42] Active and placebo 41-51 Days          
Gibson 1985 [43] Active treatment 2 Weeks       
Gibson 1985 [43] Active treatment 4 Weeks        
Gibson 1985 [43] Active treatment 12 Weeks           
Gibson 1985 [43] Placebo control 2 Weeks       
Gibson 1985 [43] Placebo control 4 Weeks        
Gibson 1985 [43] Placebo control 12 Weeks        
Cleary 1994 [47] Placebo control 15 Weeks       
Andersson 1999 [44] No treatment 12 Weeks    
Burton 2000 [45] Placebo control 2 Weeks       
Burton 2000 [45] Placebo control 6 Weeks          
Burton 2000 [45] Placebo control 12 Months       
Licciardone 2003 [46] Placebo control 1 Month       
Licciardone 2003 [46] Placebo control 3 Months        
Licciardone 2003 [46] Placebo control 6 Months           
Licciardone 2003 [46] No treatment 1 Month         
Licciardone 2003 [46] No treatment 3 Months       
Licciardone 2003 [46] No treatment 6 Months      
Number of contrasts in analysis 88866667 2 0 666555 1 6 4 444333 1 0 44433 1 0 5559755554333
Direction of effect favors OMT    
Statistically significant effect         
Reversal of significance with random-effects model  
Test of homogeneity is statistically significant  
Overall analysis
Active/placebo Short United Kingdom United States Long
Stratified analyses
Control treatment Country where trial was performed Duration of follow-up
IntermediateBMC Musculoskeletal Disorders 2005, 6:43 http://www.biomedcentral.com/1471-2474/6/43
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efits are long lasting, and to assess the cost-effectiveness of
OMT as a complementary treatment for low back pain.
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